UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LDL-C treatment gaps in statin-treated patients at high and very high cardiovascular risk in Europe

Atherosclerosis, 2014-08, Vol.235 (2), p.e106-e106

2014

Volltextzugriff (PDF)

Statin treated patients at very high cardiovascular risk in Europe: Are the majority close to LDL-C

Atherosclerosis, 2014-08, Vol.235 (2), p.e35-e35

2014

Volltextzugriff (PDF)

Low LDL-C target achievement among treated acs patients in germany: the dyslipidemia international study (dysis) iiacs results

Atherosclerosis, 2015-07, Vol.241 (1), p.e201-e202

2015

Volltextzugriff (PDF)

Prevalence of lipid abnormalities among treated ACS patients in Greece: The Dyslipidemia International Study (DYSIS) II ACS results

Atherosclerosis, 2015-07, Vol.241 (1), p.e130-e130

2015

Volltextzugriff (PDF)

Lipid abnormalities remain high among diabetic patients with stable CHD: Results of the Dyslipidemia International Study (DYSIS) II Belgium

Atherosclerosis, 2015-07, Vol.241 (1), p.e130-e130

2015

Volltextzugriff (PDF)

How many CCS- and ACS-patients might reach the newly recommended LDL-C-target <55mg/dl in clinical practice if guidelines were applied – an estimate from the DYSIS II study population

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

(648) - Mean Pulmonary Artery Pressure and Disability in Pulmonary Hypertension: An Analysis of the STELLAR Trial

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S313-S314

2024

Volltextzugriff (PDF)

(646) - Rate of Physician Visits and Hospitalizations in Pulmonary Arterial Hypertension in Argentina, Brazil, Colombia, and Mexico

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S312-S313

2024

Volltextzugriff (PDF)

(863) - Camphor Quality of Life Scores for Patients Diagnosed with Pulmonary Arterial Hypertension in Brazil and Colombia

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S408-S409

2024

Volltextzugriff (PDF)

(647) - Journey from Symptoms to Diagnosis in Pulmonary Arterial Hypertension: Results from a Cross-Sectional Survey of Real-World Patients in Latin America

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S313-S313

2024

Volltextzugriff (PDF)

P651Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

(214) - Prediction of Long-Term Survival by Three Risk Assessment Models in Patients with Pulmonary Arterial Hypertension: A SPAHR Analysis

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S115-S115

2024

Volltextzugriff (PDF)

PCV9 Budget IMPACT Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event in the United States

Value in health, 2021-06, Vol.24, p.S68-S68

2021

Volltextzugriff (PDF)

P781Better LDL-cholesterol-target attainment in patients with ACS and type 2 diabetes - results of DYSIS II ACS

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

European heart journal, 2018-08, Vol.39 (suppl_1)

2018

Volltextzugriff (PDF)

P828Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

Value in health, 2020-05, Vol.23, p.S116-S116

2020

Volltextzugriff (PDF)

N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events

ESC Heart Failure, 2024-04, Vol.11 (2), p.759-771

2024

Volltextzugriff (PDF)

P173Low LDL-cholesterol goal attainment 4 months after ACS due to lack of adjustment in lipid lowering treatment: Results from DYSIS II

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

P629Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS)

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with outcomes: an analysis of the swedish heart failure registry and the stockholm creatinine measurements cohorts

EUROPEAN JOURNAL OF HEART FAILURE, 2023, Vol.25, p.135

2023

Volltextzugriff (PDF)

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

European heart journal. Quality of care & clinical outcomes, 2021-01, Vol.7 (1), p.59-67

2021

Volltextzugriff (PDF)

Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

Singapore medical journal, 2019-09, Vol.60 (9), p.454-462

2019

Volltextzugriff (PDF)

Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

EUROPEAN HEART JOURNAL, 2019, Vol.40, p.429

2019

Volltextzugriff (PDF)

Improvement in achievement of lipid targets in France: comparison of data from the DYSIS I and DYSIS II studies

Archives of cardiovascular diseases supplements, 2017-01, Vol.9 (1), p.108-109

2017

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(52)
Tagungsberichte
(2)

Sprache

Englisch
(47)
Deutsch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

LDL-C treatment gaps in statin-treated patients at high and very high cardiovascular risk in Europe

Statin treated patients at very high cardiovascular risk in Europe: Are the majority close to LDL-C

Low LDL-C target achievement among treated acs patients in germany: the dyslipidemia international study (dysis) iiacs results

Prevalence of lipid abnormalities among treated ACS patients in Greece: The Dyslipidemia International Study (DYSIS) II ACS results

Lipid abnormalities remain high among diabetic patients with stable CHD: Results of the Dyslipidemia International Study (DYSIS) II Belgium

How many CCS- and ACS-patients might reach the newly recommended LDL-C-target <55mg/dl in clinical practice if guidelines were applied – an estimate from the DYSIS II study population

(648) - Mean Pulmonary Artery Pressure and Disability in Pulmonary Hypertension: An Analysis of the STELLAR Trial

(646) - Rate of Physician Visits and Hospitalizations in Pulmonary Arterial Hypertension in Argentina, Brazil, Colombia, and Mexico

(863) - Camphor Quality of Life Scores for Patients Diagnosed with Pulmonary Arterial Hypertension in Brazil and Colombia

(647) - Journey from Symptoms to Diagnosis in Pulmonary Arterial Hypertension: Results from a Cross-Sectional Survey of Real-World Patients in Latin America

P651Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS

(214) - Prediction of Long-Term Survival by Three Risk Assessment Models in Patients with Pulmonary Arterial Hypertension: A SPAHR Analysis

PCV9 Budget IMPACT Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event in the United States

P781Better LDL-cholesterol-target attainment in patients with ACS and type 2 diabetes - results of DYSIS II ACS

P5383Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

P828Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

PDB45 THE BUDGET IMPACT OF SITAGLIPTIN VERSUS ORAL SEMAGLUTIDE FROM A US PAYER PERSPECTIVE

N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events

P173Low LDL-cholesterol goal attainment 4 months after ACS due to lack of adjustment in lipid lowering treatment: Results from DYSIS II

P629Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS)

N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with outcomes: an analysis of the swedish heart failure registry and the stockholm creatinine measurements cohorts

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II

Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study

Improvement in achievement of lipid targets in France: comparison of data from the DYSIS I and DYSIS II studies

Suchergebnisse filtern